ONCOLYTICS BIOTECH INC's ticker is ONCYF and the CUSIP is 682310107. A total of 33 filers reported holding ONCOLYTICS BIOTECH INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $13,000 | 0.0% | 29,645 | +15.1% | 0.00% | – |
Q2 2015 | $13,000 | -53.6% | 25,762 | -33.6% | 0.00% | – |
Q1 2015 | $28,000 | +75.0% | 38,803 | +26.9% | 0.00% | – |
Q4 2014 | $16,000 | 0.0% | 30,566 | +10.0% | 0.00% | – |
Q3 2014 | $16,000 | -30.4% | 27,775 | +60.2% | 0.00% | – |
Q2 2014 | $23,000 | -23.3% | 17,342 | +3.1% | 0.00% | – |
Q1 2014 | $30,000 | +57.9% | 16,816 | +31.0% | 0.00% | – |
Q4 2013 | $19,000 | -87.3% | 12,837 | -79.2% | 0.00% | – |
Q3 2013 | $150,000 | +400.0% | 61,781 | +478.5% | 0.00% | – |
Q2 2013 | $30,000 | – | 10,680 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXT Financial Group, Inc | 43,000 | $19,000 | 0.01% |
VSR Financial Services, Inc. | 119,630 | $54,000 | 0.01% |
TCI Wealth Advisors, Inc. | 1,200 | $1,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 11,944 | $5,000 | 0.00% |
STIFEL FINANCIAL CORP | 24,500 | $11,000 | 0.00% |
FIRST MANHATTAN CO. LLC. | 1,000 | $0 | 0.00% |
WELLS FARGO & COMPANY/MN | 1,000 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 38,529 | $18,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 44,017 | $20,000 | 0.00% |
HOWE & RUSLING INC | 1,017 | $0 | 0.00% |